Intraosseous basivertebral nerve ablation: Pooled long-term outcomes from two prospective clinical trials.

ABSTRACT:

Background

Vertebrogenic pain is an established source of anterior column chronic low back pain (CLBP) resulting from damaged vertebral endplates with pain signals transmitted by the basivertebral nerve (BVN). Type 1 or Type 2 Modic changes on magnetic resonance imaging (MRI) are objective biomarkers for vertebrogenic pain. Radiofrequency ablation of the BVN (BVNA) has demonstrated both efficacy and effectiveness for the treatment of vertebrogenic pain in two randomized trials. Here, we report 3-year aggregate results from two prospective studies of BVNA-treated patients.

Methods

Pooled results at 3 years post-BVNA are reported for two studies with similar inclusion/exclusion criteria and outcomes measurements: 1) a prospective, open label, single-arm follow-up of the treatm

SUBMITTER: Smuck M 

PROVIDER: S-EPMC11373002 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature